Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Fear of Eye Treatment Leaving Thousands at Risk of Sight Loss, Specsavers Reveals


News provided by

Specsavers

19 Jun, 2026, 08:36 GMT

Share this article

Share toX

Share this article

Share toX

 Alison Hammond has teamed up with Specsavers to uncover the reality of sight-threatening eye conditions affecting millions of Brits – highlighting the importance of regular eye tests for early detection.

  • New research reveals thousands are delaying or avoiding treatment for conditions such as cataracts, glaucoma and AMD, due to 'eye anxiety' – the fear of having procedures on their eyes.
  • One in three of those with a progressive eye condition have delayed treatment and of those who delayed, one in 10 lost their eyesight completely.
  • Alison Hammond returns to Specsavers as 'The Recruit' in a new mini-series. The series follows patients from diagnosis to recovery. Its aim is to address fears associated with eye condition treatment.

LONDON, June 19, 2026 /PRNewswire/ -- New Specsavers research reveals that 73% of adults feel most anxious about eye treatment, more than any other body part.[1] The condition, termed 'eye anxiety,' is widespread across England. It can lead to delayed care for serious eye conditions including cataracts, glaucoma, and age-related macular (AMD).

Continue Reading
This image opens in the lightbox
Alison Hammond heads behind the scenes as the Specsavers Recruit to learn more about how sight-threatening conditions like glaucoma, AMD and cataracts are detected and treated. Alison shadows Specsavers optometrist Preet, seeing how routine eye tests at Specsavers can detect serious eye conditions – followed by visiting a Newmedica eye clinic to see what modern treatment really looks like.
Speed
Speed
This image opens in the lightbox
Alison shadowed the team at Specsavers
This image opens in the lightbox
Meeting delighted patients at Newmedica

The Specsavers commissioned survey of 2,000 adults in England found that 33% have been diagnosed with a serious eye condition, including glaucoma, cataracts, or AMD. Of those diagnosed, 31% delayed or postponed treatment.[2] Over half of those who delayed (55%) waited four months or longer. Around 11% have still not sought any treatment.

Delaying treatment carries serious consequences. Around 12% of those surveyed who postponed care lost their eyesight completely. Two million people in the UK currently live with sight loss.[3] More than half are blind or partially sighted due to an irreversible condition, such as AMD or glaucoma. Early treatment is vital.

Routine eye tests are critical for early detection of glaucoma, cataracts, and AMD. Specsavers optometrists receive ongoing professional development and training from ophthalmology providers including Newmedica. Newmedica is part of the Specsavers family.

When further treatment is required, patients have the choice to seek treatment or surgical intervention at specialist eye clinics - including Newmedica.

In the new three-part mini-series, Alison returns to Specsavers as 'The Recruit.' She shadowed Preet Bhara, optometry director at Specsavers Canley, observing how routine eye tests detect sight-threatening conditions. She then visited Newmedica Birmingham to witness modern eye treatment firsthand. Patients shared the impact of sight-saving procedures on their lives.

This is a topic close to Alison's heart. As someone who has a family history of glaucoma, Alison is on a mission to replace fear with understanding, by witnessing first-hand the compassion and clinical rigour that goes into every consultation and procedure.

Alison comments, "Meeting people who were genuinely anxious about their eye surgery or treatment really stayed with me. I completely understand it, especially as someone with a family history of glaucoma – your eyes are so precious, so fear can take over when they're involved.

"But after spending time with the teams at Specsavers and Newmedica and then seeing those same patients after their procedures, the difference was incredible. Seeing their relief, and how much their confidence came back – that was genuinely emotional. It showed me just how life-changing the right care can be."

The research from Specsavers reveals the specific fears driving treatment delays.[4] Of those who delayed, 34% feared something would go wrong during surgery. A further 21% postponed as they did not understand what treatment would involve. Among those who completed treatment,[5] 60% said they should have sought care sooner. Nearly 73% reported improved emotional wellbeing after treatment.

Preet Bhara, Specsavers Canley optometry director, explains, "Cataracts, glaucoma and AMD are among the leading causes of vision loss in the UK, collectively affecting millions of people. While these conditions can often be picked up during a routine eye test, research shows that a whopping 19 million people are failing to keep up with them[6].

"At Specsavers, our expert optometrists are trained to deliver comprehensive eye checks that can help to detect early signs of serious eye conditions. We recommend getting your eyes checked every two years – as catching these conditions early can often be the difference between preserving someone's eyesight and losing it."

Ash Sharma, Consultant Ophthalmologist at Newmedica Birmingham, adds, "By the time patients reach us for treatment, many are understandably anxious about the procedure and the results. However, modern eye procedures are highly advanced, quick, and deliver excellent outcomes for the majority of people. Part of our role is helping patients feel informed and reassured, so they feel confident seeking treatment sooner. Improving vision can have a profound impact on overall quality of life."

Charles, AMD patient, says, "I'll admit, when I was first told I needed injections in my eye to treat my AMD, I was petrified. But the team at Newmedica put me at ease completely – after my first two injections, the blur affecting the vision in my left eye has already noticeably decreased. This improvement in my vision has made such a positive impact, allowing me to continue living a full and independent life. I'm incredibly grateful I was seen so quickly."

Delayed eye tests and treatment can cause sight loss. Specsavers and Newmedica together support over 500,000 patients every year, from detection through to treatment.[7]

For more information about the campaign and to watch the exclusive mini-series, visit Specsavers' YouTube Channel.

Notes to Editors

All statistics unless otherwise stated are from a survey carried out by OnePoll on behalf of Specsavers among 2,000 adults in England in April 2026. Survey sample size was 2,000 adults, with 1,111 people aged 50+.

Of the full sample:

  • 666 people were diagnosed with cataracts, glaucoma, and age-related macular degeneration
  • 303 people have received treatment for said serious eye condition
  • 178 have delayed or postponed when told they required treatment

About The Recruit Film

Featuring in the film are customers Charles, Elfyn, and Margaret, all based in the Birmingham area. Case study stories available, on request.

Interviews with Preet Bhara, Optometry Director of Specsavers Canley, and Ash Sharma, Consultant Ophthalmologist at Newmedica Birmingham, can also be arranged.

References

[1] This online survey of 2,000 English Adults (with at least 1,000 aged 50+) was commissioned on behalf of Specsavers and conducted by market research company OnePoll, in accordance with the Market Research Society's code of conduct. Data was collected between 17/04/2026 and 23/04/2026. OnePoll are MRS Company Partners, corporate membership of ESOMAR and Members of the British Polling Council. Of the full sample, 666 people were diagnosed with cataracts, glaucoma or age-related macular degeneration (AMD).
[2] 178 out of the 666 diagnosed with a serious eye condition have delayed or postponed treatment.
[3] RNIB (2023). Key information and statistics on sight loss in the UK. Retrieved 20th March 2023.
[4] Of those who were diagnosed with a serious eye condition and told they required treatment, 178 reported that they delayed or postponed treatment.
[5] Of the 2,000 sampled and 666 diagnosed with a serious eye condition, 303 reported that they have completed treatment.
[6] Association of Optometrists. 2023.
[7] Calculated from internal Specsavers and Newmedica data between March 2023–February 2026. 

Modal title

Also from this source

Are Children's Eye Tests on Your List? New Specsavers Research Shows Parents Search Everything About Their Kids Except Their Vision

Are Children's Eye Tests on Your List? New Specsavers Research Shows Parents Search Everything About Their Kids Except Their Vision

New research from Specsavers – The Specsavers Children's Vision Report 2026 – reveals that the average UK parent searches online 5.3 times a week to...

Specsavers Partners with Relationship Expert Paul Brunson to Reveal How Hearing Loss Affects Connection

Specsavers, the UK's biggest optical and hearing care provider, has partnered with celebrity relationship expert Paul Brunson to launch a campaign...

More Releases From This Source

Explore

Mental Health

Mental Health

Retail

Retail

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.